DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,873,837 | -23.2% | 136,533 | -25.7% | 0.55% | -13.2% |
Q2 2023 | $44,090,160 | -48.2% | 183,709 | -45.6% | 0.63% | -49.0% |
Q1 2023 | $85,036,028 | -12.5% | 337,391 | -7.9% | 1.23% | -4.4% |
Q4 2022 | $97,236,617 | +2.5% | 366,350 | -0.3% | 1.29% | -5.2% |
Q3 2022 | $94,905,000 | +2.8% | 367,435 | +0.9% | 1.36% | +4.4% |
Q2 2022 | $92,290,000 | -11.9% | 364,036 | +2.0% | 1.30% | +7.3% |
Q1 2022 | $104,737,000 | -46.2% | 357,062 | -39.7% | 1.22% | -39.4% |
Q4 2021 | $194,708,000 | +40.0% | 591,800 | +29.6% | 2.01% | +42.2% |
Q3 2021 | $139,031,000 | +7.3% | 456,679 | -5.4% | 1.41% | +11.5% |
Q2 2021 | $129,602,000 | +21.7% | 482,940 | +2.1% | 1.26% | +12.2% |
Q1 2021 | $106,494,000 | -10.2% | 473,140 | -11.4% | 1.13% | -17.0% |
Q4 2020 | $118,577,000 | +21.5% | 533,794 | +17.7% | 1.36% | +0.7% |
Q3 2020 | $97,627,000 | +22.2% | 453,384 | +0.4% | 1.35% | +19.4% |
Q2 2020 | $79,862,000 | +67.0% | 451,633 | +30.7% | 1.13% | +21.9% |
Q1 2020 | $47,818,000 | -15.0% | 345,481 | -5.8% | 0.93% | +3.9% |
Q4 2019 | $56,265,000 | +4.8% | 366,593 | -1.4% | 0.89% | -10.7% |
Q3 2019 | $53,694,000 | +7.1% | 371,763 | +6.0% | 1.00% | +16.7% |
Q2 2019 | $50,122,000 | +11.1% | 350,698 | +2.6% | 0.86% | -65.5% |
Q1 2019 | $45,122,000 | +31.4% | 341,784 | +2.7% | 2.48% | +10.0% |
Q4 2018 | $34,328,000 | +24.9% | 332,896 | +31.6% | 2.26% | +29.4% |
Q3 2018 | $27,493,000 | +27.5% | 253,016 | +15.8% | 1.74% | -5.1% |
Q2 2018 | $21,558,000 | +9.0% | 218,465 | +8.2% | 1.84% | -6.2% |
Q1 2018 | $19,778,000 | +5.5% | 202,000 | 0.0% | 1.96% | 0.0% |
Q4 2017 | $18,750,000 | +37.6% | 202,000 | +27.2% | 1.96% | +37.5% |
Q3 2017 | $13,622,000 | +12.9% | 158,800 | +11.0% | 1.42% | -0.1% |
Q2 2017 | $12,068,000 | +23.8% | 143,000 | +25.4% | 1.43% | +9.9% |
Q1 2017 | $9,750,000 | +69.3% | 114,000 | +54.1% | 1.30% | +10.1% |
Q4 2016 | $5,760,000 | – | 74,000 | – | 1.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |